Neovacs S.A. (EPA:ALNEV)

Neovacs Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.04	0.44	0.89	0.04	16.25	10.07
Short-Term Investments	-	0	-	6.72	16.84	-
Cash & Short-Term Investments	0.04	0.44	0.89	6.76	33.09	10.07
Cash Growth	-83.37%	-50.91%	-86.87%	-79.57%	228.45%	675.67%
Accounts Receivable	0.37	0.31	0.57	0.01	0.01	0.08
Other Receivables	2.2	1.65	2.21	1.8	1.59	2.76
Receivables	2.57	1.95	2.78	1.81	1.6	2.83
Prepaid Expenses	0.09	0.08	0.07	0.49	0.05	0.16
Other Current Assets	-0	0.01	0.08	0.01	0.04	0.03
Total Current Assets	2.7	2.48	3.81	9.07	34.78	13.1
Property, Plant & Equipment	0.33	0.41	0.53	0.51	0.51	0.26
Long-Term Investments	19.47	18.68	41.49	42.33	13.27	0.18
Other Intangible Assets	0	0	0	0	0	-
Other Long-Term Assets	0.58	0.5	3.83	0.89	0	0
Total Assets	23.07	22.07	52.56	55.29	48.55	13.53

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Accounts Payable	2.64	2.28	1.98	1.93	1.32	1.29
Accrued Expenses	0.05	1.04	0.02	0.04	0.56	0.28
Short-Term Debt	0	0	0	0	0.01	0
Current Portion of Long-Term Debt	0.17	0.23	0.65	-	-	-
Current Income Taxes Payable	1.14	0.29	0.98	1.4	0.32	0.47
Other Current Liabilities	0.01	0.01	0.08	0.01	0.02	0.08
Total Current Liabilities	4.01	3.84	3.71	3.38	2.22	2.11
Long-Term Debt	-	-	-	1.2	1.03	0.39
Other Long-Term Liabilities	0.17	0.17	0.01	0.55	1.4	0.01
Total Liabilities	4.18	4.01	3.72	5.13	4.65	2.51

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Common Stock	0.48	0.17	0.35	0.12	1.99	0.68
Additional Paid-In Capital	78.91	77.57	141.78	139.67	135.12	103.3
Retained Earnings	-60.49	-60.34	-94.6	-89.63	-93.22	-93.96
Comprehensive Income & Other	-	0.65	1.31	-	-	1
Shareholders' Equity	18.89	18.06	48.84	50.17	43.9	11.02
Total Liabilities & Equity	23.07	22.07	52.56	55.29	48.55	13.53

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	0.17	0.23	0.65	1.2	1.03	0.39
Net Cash (Debt)	-0.13	0.21	0.24	5.55	32.06	9.68
Net Cash Growth	-	-13.29%	-95.74%	-82.67%	231.12%	684.25%
Net Cash Per Share	-	-	-	0.02	16.10	0.01
Working Capital	-1.31	-1.37	0.1	5.68	32.55	10.99
Tangible Book Value	18.89	18.06	48.84	50.16	43.9	11.02
Machinery	1.41	1.41	1.33	1.25	1.12	0.67
Construction In Progress	-	-	-	-	-	0.13
Order Backlog	-	0.6	0.74	0.73	0.45	0.27

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 19, 2026

Data Sources Report a data error